fda warning on semaglutide warns about safety of 'off-brand' versions of Ozempic, Wegovy FDA adds warning to Ozempic,

Rule 67/2007

For patients seeking a non-invasive solution to mild to moderate skin laxity, Renuvion has emerged as a powerful option

Andy Cohen is sharing the way "micro-dosing" a GLP-1 weight loss drug has helped his health journey

Methods Adults with T2D treated with 2 glucose-lowering agents who initiated GLP-1 RAs or basal insulin from 2010 to 2019 were propensity-score matched (1:1) and followed until October 2021 (intention-to-treat [ITT])

Because of objections to a federal rule protecting gender dysphoria, Louisiana Attorney General Liz Murrill has joined a multi-state lawsuit seeking to invalidate Section 504, the disability law best known for providing support for public school students